Seven Eight Capital’s Editas Medicine EDIT Stock Holding History

Seven Eight Capital’s Portfolio EDIT Stock Details EDIT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-146,345	Closed	-$1.48M	–	665
2023 Q4	$1.48M	Buy	+146,345	New	+$1.28M	0.17%	183
2022 Q4	–	Sell	-22,963	Closed	-$281K	–	470
2022 Q3	$281K	Buy	+22,963	New	+$358K	0.06%	394
2022 Q1	–	Sell	-10,472	Closed	-$278K	–	577
2021 Q4	$278K	Buy	+10,472	New	+$360K	0.05%	367
2020 Q1	–	Sell	-62,300	Closed	-$1.84M	–	518
2019 Q4	$1.84M	Buy	+62,300	New	+$1.56M	0.1%	317

Other funds holding EDIT

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $94.8B AUM 24.11% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Seven Eight Capital's EDIT Position: Q1 2024 in Review

Seven Eight Capital sold out of Editas Medicine (EDIT) in Q1 2024, closing a stake of 146,345 shares — an estimated $1.48M sold.

Seven Eight Capital first reported a position in EDIT in Q4 2019 and held it in 4 quarters. The position peaked at $1.84M in Q4 2019. 225 funds tracked by Wall St. Rank hold EDIT as of Q1 2024.

Seven Eight Capital reported no remaining Editas Medicine position as of Q1 2024 after selling out during the quarter.
Seven Eight Capital sold 146,345 Editas Medicine shares in Q1 2024, an estimated $1.48M.
Seven Eight Capital first reported a position in Editas Medicine in Q4 2019 and held it in 4 quarters.
Seven Eight Capital's Editas Medicine position peaked at $1.84M in Q4 2019.
225 funds tracked by Wall St. Rank held Editas Medicine as of Q1 2024.

Based on Seven Eight Capital's 13F filing for Q1 2024, filed 13 May 2024.